Article
Trop-2 Induces Tumor Growth Through AKT and Determines Sensitivity to AKT Inhibitors
28 Mar 2016
Abstract excerpt
PURPOSE: Inhibition of AKT is a key target area for personalized cancer medicine. However, predictive markers of response to AKT inhibitors are lacking. Correspondingly, the AKT-dependent chain of command for tumor growth, which will mediate AKT-dependent therapeutic responses, remains unclear. EXPERIMENTAL DESIGN: Proteomic profiling was utilized to identify nodal hubs of the Trop-2 cancer growth-driving...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
